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Background: The beneficial effects of exercise training on depressive symptoms are
well-established. In the past years, more research attention has been drawn to the
specific effects of exercise training on depressive symptoms in somatically ill patients.
This reviews aims at providing a comprehensive overview of the current findings and
evidence of exercise interventions in somatic disorders to improve depressive symptoms.
Methods: We systematically searched PubMed and Cochrane databases and extracted
meta-analyses from somatically ill patients that underwent exercise interventions and
provided information about the outcome of depressive symptoms.
Results: Of the 4123 detected publications, 39 were selected for final analysis. Various
diseases were included (breast-cancer, prostate cancer, mixed-cancer, cardiovascular
disease, coronary heart disease, hemodialysis, fibromyalgia syndrome, acute leukemia,
other hematological malignancies, heart failure, HIV, multiple sclerosis, mixed neurological
disorders, Parkinson’s disease, stroke, ankylosing spondylitis, traumatic brain injury,
lupus erythematodes). Most meta-analyses (33/39) found beneficial effects on depressive
symptoms, but quality of the included studies as well as duration, intensity, frequency,
and type of exercise varied widely.
Conclusion: Exercise training has the potential to improve depressive symptoms in
patients with somatic disorders. For specific training recommendations, more high quality
studies with structured exercise programs and better comparability are needed.
Keywords: depressive symptoms, training, aerobic, somatic disease, comorbidity
INTRODUCTION
Depression alone and comorbid with other chronic somatic diseases accounts for significant
disease burden worldwide (1, 2). By 2030, depression is in addition to HIV/AIDS and ischemic
heart disease assumed to be one of the three leading causes of burden of disease (3). Exercise
therapy in depressive patients, as an independent intervention and as an adjunct intervention to
antidepressant medication or psychotherapy, has been discussed to improve clinical outcomes in
somatic diseases (4, 5). Compared to pharmacological treatment, the beneficial effects of exercise
seem to be similar and are present at short-term and during follow-up periods of up to one year
(6, 7). Especially for somatically unstable patient, this offers new treatment perspectives without the
common side-effects of psychopharmacological medication. Usually both the depressive symptoms
and the underlying somatic condition improve as a consequence of exercise therapy.
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In a large World Health Survey of 245 404 participants from
60 countries, an average between 9.3 and 23.0% of participants
with one or more chronic physical diseases had comorbid
depressive symptoms (2). For numerous somatic diseases, an
association with depression is well-established. For example,
patients with multiple sclerosis (8), stroke (9), parkinson’s
disease (10), diabetes mellitus (11), breast cancer (12) or heart
failure (13) have an elevated risk for developing a major
depressive disorder (MDD). From a psychiatric perspective, it is
important to note that a recently published study with 1,237,194
participants showed that individuals who exercised (various types
of disciplines) had 1.49 (43.2%) fewer days of poor mental health
in the past month than non-exercising individuals (14).
As the comorbid physical diseases often complicate the
pharmacological treatment of depressive symptoms, further
research approaches with a focus on alternative therapy options
are urgently needed. Based on the beneficial effects of physical
exercise in MDD (15), prior studies investigated the effects
of exercise in patients with somatic disorders and comorbid
depressive symptoms. A meta-analysis of different chronic
illnesses including stroke, ischemic heart attack, fibromyalgia,
dementia, and other psychiatric diseases, revealed a significant
overall reduction of depressive symptoms. The majority of effects
were derived from cardiovascular diseases, chronic pain and
fibromyalgia (16). The results lead to the conclusion that physical
exercise seems to have positive effects on depressive symptoms
in patients with various somatic diseases without subdividing
the different diseases with specific recommendations. However, a
comprehensive overview of the available evidence of how exercise
may improve depressive symptoms in patients with somatic
diseases is lacking.
In this systematic meta-review, we will provide a detailed
overview of recent meta-analyses evaluating different somatic
diseases with comorbid depressive symptoms. The efficacy and
the types and durations of exercise will be analyzed. Up to
date, meta-analyses of specific diseases or disease groups (e.g.,
cardiovascular diseases) have been published as well as meta-
analyses comprising different somatic diseases with an emphasis
on cardiovascular diseases, fibromyalgia and pain (16). With our
review, we aim to close this gap and point to limitations of prior
studies as well as possible future research strategies.
METHODS
We systematically searched PubMed and Cochrane databases
with all combinations of the following search terms: depressive
disorder OR depression AND exercise, depressive disorder
OR depression AND physical activity, depressive disorder OR
depression AND endurance training, depressive disorder
OR depression AND training, depressive disorder OR
depression AND resistance training, depressive disorder
OR depression AND aerobic, depression OR depressive
disorder AND somatic AND exercise, depression OR depressive
disorder AND physical illness. The database search was
last updated on 31th July 2018. All citations were screened for
relevance by title in a first step, by abstract in a second step and by
full-text in a last step. In all included meta-analyses, the citations
were screened manually for further relevant meta-analyses
that may have not been detected by the systematic search. The
systematic literature search and selection was performed by AR,
the selection was afterwards reviewed independently by SK.
Both AR and SK retrieved the relevant information and
the results were compared. In case of disagreement, a third
author (AH) was consulted. Inclusion criteria were: meta-
analysis investigating the effects of exercise on depressive
symptoms in patients with comorbid physical illness based
on interventional trials, published within the past 10 years.
Exclusion criteria contained meta-analyses published earlier
than within the past 10 years, systematic reviews without
meta-analyses, meta-analyses in non-English language, meta-
analyses only investigating depressive patients with no somatic
comorbidities, lack of data post-intervention. No limitations




The initial search without further restrictions resulted in 103,468
citations. After limiting the citations for the past 10 years, 60,430
citations remained. When only considering the meta-analyses,
4,123 citations remained and after eliminating duplicates, 981
citations were included for further analysis. The screening on
title-level eliminated 869 citations (112 remaining), the screening
on abstract-level another 63 citations (49 remaining). After
full-text screening, 39 citations remained for final analysis
(see Figure 1).
Study Characteristics
Table 1 provides an overview of the included somatic diseases.
The duration of the single studies varied between three (46)
to 52 (21) weeks, the intensity between one time (51) and
seven times (37) per week and the duration of the sessions
between 30 and 122min (16). Adherence rate was solely
reported in two meta-analyses (21, 22) and intensity of the
training with heart rate controlled exertion in one meta-analysis
(37). The interventions consisted of aerobic exercise, resistance
training, balance training, yoga, moderate cycling, walking,
nordic walking, running, swimming, tai chi chuan, qigong,
Bobath exercises, jogging, calisthenics. Across all trials, the
mean sample size was 658 with a minimum of 39 (28) and a
maximum of 3.425 (36). Depressive symptoms were rated with
different questionnaires (observer or self-assessment): BDI (Beck
Depression Inventory), CDI (Children Depression Inventory),
CES-D (Center for Epidemiological Studies Depression Scale),
DASS (Depression Anxiety Stress Scales), GDS (Geriatric
Depression Scale), HAD (Hospital Anxiety and Depression
Scale), HAM-D (Hamilton Rating Scale for Depression), SCL-
90 (Symptom Checklist-90), TAS (Toronto Attitude Scale),
POMS (Profile of Mood States), SAS (Symptom Assessment
Scale), CSDD (Cornell Scale for Depression in Dementia),
IDS-SR (Inventory of Depressive Symptomatology Self Report),
LPD (Levine-Pilowsky Depression Questionnaire), MADRS
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FIGURE 1 | Flow-chart of included citations.






Breast cancer 7 (17–23)
Mixed cancer types 7 (24–30)
Prostate cancer 3 (31–33)
Cardiovascular disease 1 (34)
Coronary Heart disease 1 (35)
Heart failure 2 (36, 37)
Intradialytic patients 2 (38, 39)
Hemodialysis patients 1 (40)
Fibromyalgia 2 (41, 42)
Ankylosing spondylitis 1 (43)
Lupus erythematodes 1 (44)
Acute leukemia 1 (45)
Hematological malignancies 1 (46)
HIV 1 (47)




Parkinson disease 1 (51)
Stroke 2 (52, 53)
Traumatic brain injury 1 (54)
Total 39
HIV, human immunodeficiency virus.
(Montgomery-Asberg Depression Rating Scale), MDI (Major
Depression Inventory), POMS (Profile of Mood States), QOL
(Quality of Life), DASS (Depression Anxiety Stress Scales), TAS
(Toronto Attitude Scale), MAACL (Multiple Affect Adjective
Checklist), HDCDS (Hare-Davis Cardiac Depression Scale),
SDS (Self-rating Depression Scale), BSI-18 (Brief Symptom
Inventory). Thus, in the different meta-analyses, various different
questionnaires were used, most often self-rating questionnaires:
the BDI I/II in 26, the HADS in 18 and the CES-D in 17 meta-
analyses. Themajority of meta-analyses includedmore than three
different questionnaires. As observer-rating scales, HAMD was
used in four and MADRS in three meta-analyses.
Risk of Bias Within and Across Studies
Most meta-analyses (51) reported about different cancer-type
patients followed by neurological disorders (7). For other
diseases, such as HIV, only one meta-analysis could be identified.
The variety of exercise modalities and the different durations
of interventions lead to a reduced general transferability of
the conclusions. Recommendations regarding effects of specific
interventions on depressive symptoms in specific somatic
conditions can hardly be drawn. None of the trials included in the
respective meta-analyses could be declared double-blind as this is
challenging to fulfill with exercise interventions. The application
of various different rating-scales is another potential risk of
bias. Moreover, most of the included studies in the respective
meta-analyses did not define depressive symptoms as primary
outcome parameter.
Results of Individual Studies
A detailed summary of the included studies with
inclusion/exclusion criteria, study population, intervention
summary and outcomes is provided in Tables 2, 3.
Exercise Interventions in Cancer Patients
Exercise interventions in breast cancer patients
Our search resulted in seven meta-analyses that met the
inclusion criteria. The majority found positive effects of
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TABLE 3 | Outcomes of the included meta-analyses.
References Results/Main Outcomes
Adamson et al. (50) Results from the meta-analysis yielded a small but statistically significant effect of 0.28 for depression reduction overall (SE = 0.07; 95%
CI: 0.15 to 0.41; p = 0.00).
The effect of exercise on depression is slightly larger (0.36) in the MS studies compared with the other studies (0.20), but this difference
was not statistically significant.
Bergenthal et al. (46) The pooled result of three trials (N = 249) for depression shows a statistically significant benefit for the exercise arm (SMD = 0.25; 95%
CI:−0.00 to 0.50; p = 0.05).
Brown et al. (24) Exercise provided a small overall reduction in depressive symptoms compared to standard care among all types of cancer ds = −0.13,
95% CI: −0.26 to −0.01).
Collectively, the 40 effect sizes lacked homogeneity I2 = 55%, 95% CI: 35 to 68, p < 0.001.
Subgroup analysis by cancer type revealed significant reductions in depressive symptoms among breast cancer survivors d = −0.17,
95% CI: −0.32 to −0.02, but no significant difference in depressive symptoms among prostate, leukemia, lymphoma, and colorectal
cancer survivors.
Buffart et al. (25) After excluding outliers, yoga resulted in significant large reductions in depression (d = −0.69; 95% CI: 1.02 to −0.37).
Carayol et al. (17) Exercise resulted in an improvement of depressive symptoms (d = −0.275, 95% CI: −0.457 to −0.094, p = 0.003). I2 = 39% (p = 0.09).
Chung et al. (38) Exercise improved depressive symptoms (d = −1.233, SE = 0.482, 95% CI: −2.177 to −0.289, p = 0.010).
Heterogeneity: χ2 = 23.80,p < 0.001; I2 = 87.40%
Craft et al. (26) Mean ES of (−0.22, 95% CI: −0.43 to −0.009; p = 0.04) under a random effects model, when comparing exercise interventions to
control groups.
Cramer et al. (19) Evidence for large short-term effects were found for depression (SMD = −1.59, 95% CI: −2.68 to −0.51; p < 0.01).
Heterogeneity: Chi² = 84.03, df = 5 (p < 0.00001); I² = 94%
Long-term effects (2 studies, N = 43) of up to 24 weeks did not show significant results.
Cramer et al. (18) Comparison of yoga vs. no therapy: Yoga did not appear to reduce depression (pooled SMD = −0.13, 95% CI −0.31 to 0.05; seven
studies, 496 participants; low-quality evidence).
Comparison of yoga vs. psychosocial/educational interventions provided moderate-quality evidence indicating that yoga can reduce
depression (pooled SMD = −2.29, 95% CI: −3.97 to −0.61; 4 studies, 226 participants).
Dalgas et al. (48) In summary the meta-analysis indicated a small beneficial effect of exercise on depressive symptoms in people with MS. The SMD across
studies was(g = −0.37, 95% CI: −0.56 to −0.17).
Eng and Reime (52) Overall, physical exercise resulted in less depressive symptoms over 13 studies involving 1022 patients (SMD = −0.13, 95% CI: −0.26 to
−0.01, I2 = 6%, p = 0.03) with low heterogeneity.
Ten studies evaluated the effect on depressive symptoms after a period of time had elapsed following the exercise sessions (range from
10 weeks to 9 months). Physical exercise did not change depressive symptoms over these 10 follow-up studies involving 889 patients
(SMD = −0.04, 95% CI: −0.17 to 0.09, I2 = 1%, p = 0.53).
Ensari et al. (49) The weighted mean ES was small, but statistically significant (g = 0.36, SE = 0.09, 95% CI: 0.18 to 0.54, Z = 3.92, p < 0.001), indicating
the exercise training resulted in an improvement in depressive symptoms compared to control.
Fong et al. (27) Measured by the Beck depression inventory, physical activity was associated with reduced depression (−4.1, 95% CI: −6.5 to −1.8; p <
0.01) in survivors of mixed types of cancer.
Four other studies in the sample used the HADS (two) or POMS (two). The results for HADS were (−0.5, 95%CI: −2.8 to 1.7, p = 0.64
and for POMS −7.5, 95 CI:−16.0 to 1.0, p = 0.09).
Furmaniak et al. (20) Exercise may lead to little or no improvement in depression (SMD = −0.15, 95% CI: −0.30 to 0.01, test for overall effect: Z = 1.86;
p = 0.062).
Heterogeneity: Tau2 = 0.0; Chi2 = 3.73, df = 5; p = 0.59; I2 = 0.0%.
Gomes Neto et al. (39) Exercise lead to a reduction in depression symptoms (−7.32; 95% CI: −9.31 to −5.33). Test for overall effect size Z = 7.21, p < 0.00001.
Graven et al. (53) When the data from the two studies was pooled; (SMD = −2.03, 95% CI: −3.22 to −0.85) immediately after the intervention phase (note,
different time points were used in the two studies for the follow-up assessment).
Herring et al. (16) Exercise training significantly reduced depressive symptoms by a heterogeneous mean effect of 0.55 (95% CI: 0.31 to 0.78, p < 0.001).
A significant improvement in fatigue (β = 0.37, Z = 2.21, p≤0.03) accounted for significant variation in the overall effect of exercise on
depressive symptoms.
Langhorst et al. (41) Meditative movement therapies improved depressive symptoms (SMD = −0.49, 95% CI: −0.76 to −0.22, p = 0.0004 Heterogeneity
I2 = 27%; Tau2 = 0.03).
2 studies evaluated the follow-up (N = 132), with no significant improvement of depressive symptoms.
In subgroup analyses, only Yoga yielded significant effects on depression at final treatment.
Liang et al. (43) A statistically significant difference was observed (MD = −2.31, 95% CI: −3.33 to −1.30, p = 0.001), which indicated that home-based
exercise interventionsreduced the depression scores, compared to the control groups.
No significant heterogeneity between home-based exercise groups and control groups (p = 0.24, I2 = 30%).
Lin et al. (29) Improvement of depressive symptoms (−0.95, 95% CI: −1.55 to −0.36, test for overall effect: Z = 3.15, p = 0.002).
Heterogeneity: τ2 = 0.63, χ2 = 66.81, df = 7, p < 0.00001); I2 = 90%.
Lin et al. (28) No significant effects were found for depression and health-related quality of life. (No SMD or CI provided)
(Continued)
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TABLE 3 | Continued
References Results/Main Outcomes
Liu et al. (35) The Thai Chi group had a significantly lower level of depression (SMD 9.42, 95% CI: 13.59 to 5.26, p < 0.001, I2 = 81%, N = 168)
compared with the non-active control groups.
Newby et al. (31) Exercise interventions significantly reduced depressive symptoms (Point estimate −0.961, SE = 0.319, CI 95% −1.585 to −0.337,
Z = −3.017, p = 0.003).
O’Brien et al. (47) One meta-analysis was performed and demonstrated a significant improvement in the depression-dejection subscale of the Profile of
Mood States Scale (POMS) by a reduction of 7.68 points for participants in the aerobic exercise intervention group compared with the
non-exercising control group (95% CI: −13.47 to −1.90, p = 0.009, I2 = 94%, p < 0.0001).
O’Dwyer et al. (44) A meta-analysis including three studies found significantly lower depression scores in the exercise groups compared to controls
(SMD = −0.40 SD; 95% CI: −0.71 to −0.09, test for overall effect size Z = 2.54, p = 0.01).
Patsou et al. (21) Reduction in depressive symptoms showed a small to moderate effect of depressive symptoms in favor of the exercise g = −0.38 (95%
CI −0.89 to 0.13, p = 0.14).
With regard to the type of the exercise intervention, aerobic interventions yielded a large and significant effect on depression at the last
follow-up (3–6 months) measurement compared with the control groups (g = −1.23, 95% CI: −1.97 to −0.49, p = 0.001).
Perry et al. (54) This represents a statistically significant, positive small to medium overall effect size of physical exercise to reduce depressive symptoms in
people following TBI (SMC = 0.48, 95% CI = 0.16 to 0.81).
Tests of heterogeneity were significant (p < 0.01), confirming that heterogeneity was present amongst the studies included in the analysis.
Samartzis et al. (36) Interventions using exercise training appeared more effective compared to usual care (SMD = 0.391, 95% CI: 0.213 to 0.569). There was
a trend for SSRI superiority compared to exercise training for improving depression (Q = 3.257, df = 1, p = 0.071).
Singh et al. (22) Large effect in favor of exercise SMD = 0.66, 95%, CI: 0.52 to 0.80, p < 0.01, I2 = 90%; high heterogeneity.
Intervention duration had an effect on depression (χ² = 7.93, df = 1, p < 0.01), with interventions lasting longer than 12 weeks producing
a large effect (SMD = 0 .84, 95% CI: 0.65 to 1.03, p < 0.01) and interventions lasting 12 weeks or less having a moderate effect
(SMD = 0.44, 95% CI: 0.23 to 0.65, p < 0.01).
Song et al. (51) A fixed-effect model indicated that TCQ significantly reduced depression scores compared to control groups, with an overall medium
effect size (g = −0.457, 95% CI: −0.795 to −0.118, p = 0.008). Q- value (p = 0.739) and I2 (0%) indicated limited heterogeneity.
Song et al. (40) Exercise training was able to reduce depression in HD patients (SMD =-0.95, 95% CI: −1.18 to −0.73; Z = 8.33, p < 0.00001).
Sosa-Reina et al. (42) There is strong evidence from intention-to-treat and per protocol analysis that exercise reduces symptoms of depression (−0.40, 95% CI:
−0.55 to −0.24; p < 0.001). Values of Cohen’s g suggested that exercise had a small effect on symptoms of depression.
Tu et al. (37) Strong evidence of a decrease in the symptoms of depression with exercise (SMD −0.38, 95% CI: −0.55 to −0.21, p < 0.00001) in 3–6
months follow-up.
Vashistha et al. (32) The pooled data did not reveal a significant improvement in depression (−3.02, 95%CI: −7.83 to 1.79, test for overall effect: Z = 1.23,
p = 0.22).
Heterogeneity: Tau² = 9.80; Chi² = 4.64, df = 1, p = 0.03; I² = 78%.
Wang et al. (34) The HAMD scores of patients performing TCEs improved (MD −3.97, 95% CI: −5.05 to −2.89, p < 0.001; I2 = 0, p = 0.91) compared
with those of patients in the control group, based on a random-effects model.
The POMS depression scale scores of the patients performing TCEs significantly improved (MD −3.02, 95% CI: −3.50 to −2.53, p <
0.001; I2 = 0%, p = 0.76) compared with those of patients in the control group, based on a random-effects model.
Wayne et al. (30) The overall effect size based on a random-effects model favors TCQ on depression in cancer patients (g = −0.27, 95% CI: −0.44 to
−0.11, p = 0.001). A subgroup meta-analysis limited to five RCTs using an active control group showed a statistically non-significant
trend toward TCQ improving depression (g = −0.22, 95% CI:−0.47 to 0.02, p = 0.080). A subgroup meta-analysis limited to the three
RCTs with a no-treatment control group showed a statistically positive effect of TCQ.
Ying et al. (33) No obvious difference in mitigating depression (SMD = −0.18, 95% CI: −0.54 to 0.17, p = 0.31).
Zhu et al. (23) Exercise intervention reduced depression, (SMD = −2.08, 95% CI: −3.36 to −0.80, p = 0.001, I2 = 2%, p = 0.41).
Zhou et al. (45) Based on the data for depression, there were no significant differences in these parameters between the exercise and control groups
(SMD = −0.15, 95% CI: −0.51 to 0.22, p = 0.28, p for heterogeneity = 0.57, I2 = 0%).
exercise on depressive symptoms in these cohorts (17, 21–
23, 55). Different types of interventions were summarized
(aerobic, resistance, aerobic and resistance, yoga exercises), with
one meta-analysis providing more detailed information about
differences between the exercise types: aerobic interventions
yielded a large and significant effect on depression at the
last follow-up measurement compared with the non-exercising
control group (21). Another meta-analysis pointed toward the
beneficial effects of an intervention duration of longer than
12 weeks (22).
One meta-analysis only showed little improvement in
depression after exercise intervention (20). The two remaining
meta-analyses with overlapping populations of Cramer et al.
(18, 19) were heterogeneous. In the 2012 analysis, large short-
term effects were shown (19), in the 2017 analysis these results
could not be reproduced (18).
Exercise interventions in mixed cancer-samples
Most of these meta-analyses included a majority of breast-
cancer patients.
Yoga intervention Buffart et al. showed significant large
reductions in depressive symptoms of yoga interventions, one
of the included RCTs included lymphoma patients, the other 6
trials breast cancer (25). Lin et al. (29) summarized 6/8 RCTs
with breast cancer and different forms of yoga interventions and
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showed that depressive symptoms improved significantly in the
intervention groups (29).
In the cohort of Wayne et al. breast cancer was
also the main disease. The overall effect size favored
Thai Chi and QiGong interventions on depressive
symptoms (30).
Aerobic or mixed intervention Brown et al. (24) (65% of patients
with breast cancer) found a small overall reduction in depressive
symptoms of aerobic and yoga interventions compared to
standard care among all types of cancer. Subgroup analysis
by cancer type revealed significant reductions in depressive
symptoms among breast cancer survivors, but no significant
difference in depressive symptoms among prostate, leukemia,
lymphoma, and colorectal cancer survivors.
Another meta-analysis by Craft et al. revealed modest
beneficial effects of exercise (26). Fong et al. evaluated 75% breast
cancer patients and showed different outcomes with regard to
different depression scales: measured by the BDI, physical activity
(aerobic) was associated with reduced depression. Subgroups of
four RCTs used the HAMD and POMS scales, the outcomes in
this cohort were not significant (27).
In another meta-analysis by Lin et al. (28) with
various gynecological cancer-types and various types
of activity (i.e., aerobic training, muscle strengthening,
stretching exercises or education regarding exercise)
no statistically significant improvement could be
shown. None of the included RCTs appeared in both
analyses (28).
Exercise interventions in Patients with Prostate Cancer
Three meta-analyses were found eligible for this review with
regard to prostate cancer. All of them included various types of
exercise and one meta-analysis included lifestyle interventions
consisting of exercise and other interventions (e.g., dietary
advice) (33). The largest meta-analysis with four RCTs found
significantly reduced depressive symptoms, while the two smaller
ones with 3 RCTs and 2 RCTs found no statistically significant
differences (31–33).
Exercise Interventions in Patients With
Cardiovascular Disease and Coronary Heart Disease
For cardiovascular diseases, one meta-analysis could be included
in our meta- review (34). 4 RCTs summarizing patients with
ischemic heart disease or coronary artery disease, cerebrovascular
disease, diseases of the aorta and arteries, and peripheral vascular
disease compared Thai Chi, qigong, baduanjin interventions to
control interventions (e.g., strength training or no intervention).
Both outcome measures (HAMD and POMS) showed significant
improvements in the intervention groups. One meta-analysis
with 2 RCTs/CCTs analyzed the effects of 3-months of Thai Chi
Interventions and found positive effects in the intervention group
concerning the depressive symptoms (35).
Exercise Interventions in Patients With Heart Failure
The two included meta-analyses showed an improvement in
depressive symptoms compared to standard care in large cohorts
(36, 37).
Intradialytic Exercise Interventions and Exercise
Interventions in Hemodialysis Patients
We could include two meta-analyses for the cohort of
intradialytic exercise (38, 39). Exercise interventions
included aerobic training, resistance training, or a
combination with strength training or range of motion. Both
publications showed significant improvements of depressive
symptoms (38, 39).
One meta-analysis included intradialytic exercise patients and
exercise interventions in hemodialysis patients on non-dialytic
days (40). Beneficial effects of exercise were reported.
Exercise Interventions in Patients With Fibromyalgia,
Ankylosing Spondylitis and
Lupus Erythematodes (LE)
The two citedmeta-analyses for fibromyalgia (41, 42) were able to
present improved depressive symptoms. The interventions were
heterogeneous with Tai Chi and/or Yoga, and/or Qi Gong (41)
and aerobic exercise, combined exercise, muscle strengthening,
flexibility, stretching (42).
Our search resulted in one meta-analysis that revealed a
statistically significant beneficial effect of home-based stretching
exercise in reducing depressive symptoms in patients with
ankylosing spondylitis (43).
In a meta-analysis of patients with LE, significantly lower
depression scores were found in the exercise groups (stretching
or aerobic exercise) compared to controls (44).
Exercise Interventions in Patients With Acute
Leukemia and Other Hematological Malignancies
Our systematic search resulted in two meta-analyses, one
including solely acute leukemia (45) and one including various
hematological malignancies (46). Zhou et al. found no significant
differences between the exercise (aerobic exercise, mixed-
modality exercise) and control groups, whereas Bergenthal
showed a statistically significant benefit for the exercise group
with aerobic exercise or combined aerobic/strength exercise in a
larger cohort.
Exercise Interventions in Patients With HIV
We were able to identify one meta-analysis with a small
sample size and various forms of exercise interventions
(e.g., walking, jogging, cycling, rowing, stair stepping,
and swimming). A significant improvement could be
displayed in the depression-dejection sub scale of the
POMS d (47).
Exercise Interventions in Patients With
Neurological Diseases
Three meta-analyses revealed small but significantly positive
effects of exercise on depressive symptoms in multiple sclerosis
(16, 48, 49). Different forms of exercise were allowed (Aerobic,
Resistance Aerobic+, Yoga).
In Parkinson’s disease, exercise interventions (Tai Chi and/or
Qigong) led to significantly improved depressive symptoms (51).
Overall, physical exercise resulted in less depressive symptoms
in the two suitable meta-analyses of stroke patients (52, 53).
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After 10 weeks of follow-up, this beneficial effect could not be
maintained (52).
One meta-analysis included various neurological disorders
and various exercise interventions. Depressive symptoms were
significantly reduced. The effect of exercise on depression was
slightly larger in the MS studies compared with the other studies.
In addition to the above mentioned neurological disorders
(with overlapping single studies), other diseases like Alzheimer’s
disease, were included (50).
Exercise Interventions in Patients With Traumatic
Brain Injury
In one meta-analysis, two RCTs and seven non-RCTs were
included and found statistically significant, positive effects of
exercise on depressive symptoms (54).
DISCUSSION
We were able to include 39 meta-analyses confirming that the
application of exercise as an add-on treatment in patients with
somatic disorders is a frequently studied intervention. As stated
above, different reasons for this observation can be discussed: the
positive effects in depression alone (15), the principle lack of side-
effects and the overall improvement of fitness and mortality. In
our meta-review, most meta-analyses showed these (expected)
beneficial effects of exercise on depressive symptoms (33/39).
The six meta-analyses without these effects evaluated different
exercise modalities in different types of diseases (18, 20, 28,
32, 33, 45). One of these meta-analyses provided data of breast
cancer patients receiving yoga therapy and found no significant
effect on depressive symptoms of yoga when comparing to no
therapy, but did find significant improvements of depressive
symptoms when comparing yoga to psychosocial intervention (7
and 4 included trials) (18). Another meta-analysis with breast-
cancer patients found no significant results (20). The smallest
of the included meta-analyses with 39 participants (2 trials)
also evaluated depressive symptoms in any type of gynecological
cancer and found no significant effects (28). Neither of the
two meta-analyses with prostate cancer patients nor the meta-
analyses with acute lymphoblastic leukemia (ALL) patients found
significant reductions in depressive symptoms (32, 33, 45).
Five meta-analyses reported long-term effects with follow-
up periods from 3 to 9 months of the exercise interventions
(19, 21, 37, 41, 52). The results were heterogeneous with two
meta-analyses showing no significant effects in a 3 to 9 months
period (19, 52). One meta-analysis only found positive long-term
effects during 3 to 6 months for one of the possible exercise
interventions in subgroup analyses (41). The two remaining
meta-analyses pointed to positive long-term effects in a 3–6
months period (21, 37). In all of these studies except one (37)
the follow-up cohort was much smaller compared to the overall
sample size. The small sample sizes on the one hand and the small
number of meta-analyses in total restrict the generalizability of
these results. Future studies should include a follow-up period of
at least 3 months (preferably three and 3 months assessments) to
accumulate data for meaningful statements.
Following the American College of Sports Medicine (ACSM)
guidelines, healthy adults should engage in moderate aerobic
exercise training for ≥30min per day on ≥5 days per week,
vigorous aerobic exercise training for ≥20min per day on ≥3
days per week, or a combination of both moderate and vigorous
aerobic training. On another 2–3 days, healthy adults should
perform resistance exercises for each of the major muscle groups
and flexibility exercises for each major muscle-tendon groups
on ≥2 days per week (56). Future studies should lean on these
recommendations to help homogenize the results.
In literature, many different rating scales (self- and observer-
rating) have been introduced to assess depressive symptoms,
reflecting the variety of questionnaires used in the original
trials and the consecutive meta-analyses. For example, the
practice guidelines for the treatment of depression in Germany
(57) list nine possible questionnaires as valid tools. In specific
somatic disorders, validation studies of the most often used
scales were performed: HAMD for multiple sclerosis patient
(58) and for stroke patients (59). BDI for cancer patients (60)
and heart failure patients (61). In a mixed cancer population,
a review recommended the CES-D as most precise instrument
if depression is the sole focus (62). It has been stated that
discrepancies between BDI andHAMD scores (self- and observer
rating scales) could be due to different personality traits (e.g.,
high neuroticism is associated with higher BDI scores) and
that therefore both should be regarded separately (63). To date,
valid recommendations for all included somatic disorders or
general recommendations for specific questionnaires to access
depressive symptoms could not be identified. For future studies,
similar outcome measured should be implemented to ensure
comparability and both self- and observer rating scales should
be combined.
The possible reasons for the varying observations regarding
the different intervention types and the measuring time points
could be the same reasons that complicate meta-analyses of the
existing exercise trials. As stated above, in none of the meta-
analyses, the included trials had matching exercise protocols
regarding type, duration and frequency of the intervention.
Most often no data was provided about the attendance rate of
the participants and about the aerobic capacity before/after the
intervention as a controlling variable. The quality of the trials
ranged from very low to good quality (also with regard to the
exercise-specific difficulty of blinding the intervention). In none
of the meta-analyses the depressive symptoms after the exercise
intervention were the primary endpoint in all of the included
trials, so moreover the validity of the conclusions has to be
discussed cautiously.
In summary, we were able to identify a large interest in this
field of research for the above demonstrated reasons. In most of
the meta-analyses, regardless of the underlying somatic disease,
beneficial effects of exercise on depressive symptoms could
be observed—keeping in mind that depressive symptoms were
mainly secondary outcomes in the included studies. Some of the
somatic diseases, especially cancer and in this field breast cancer,
were overrepresented compared to others like heart failure.
More standardized trials with better comparability are
required to draw specific conclusions about the recommended
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type and duration of exercise in different diseases. The current
findings point to beneficial effects of various forms of exercise,
but the implementation in guidelines and for example in therapy
strategies that are supported more extensively is still difficult
because of the lack of clarity of specific outcomes. Especially the
diversity of outcome parameters impedes the comparability of
interventions within and between somatic disorders. Moreover,
most meta-analyses did not report types of other antidepressant
interventions like medication or psychotherapy. Thus, it is
difficult to answer the question whether exercise therapy is
efficient as an add-on treatment to an ongoing pharmaco-
or psychotherapy or whether it should be offered as a single
intervention in patients with somatic disorders and depression.
Finally, information is sparse regarding whether patients
continue to exercise after the intervention (e.g., in sport clubs) or
whether their overall activity level (e.g., measured by pedometers
or more accurately by accelerometers) increases and how this is
related to outcome.
CONCLUSION
In this meta-review, we provide an overview of existing
evidence for the effects of exercise on depressive symptoms
in various somatic disorders. The results are promising,
but meaningful recommendations are lacking because of
heterogeneous study protocols. For better comparability, we
would recommend to implement the following standards in
future studies: homogeneous outcome measures, one self-rating
scale (e.g., BDI) and one observer-rating scale (e.g., HAMD or
MADRS). Moreover, specific information of other antidepressant
treatments (especially medication and psychotherapy) should
be consistently reported. State and duration of the somatic
disease should be provided. Future studies should lean on
recommendation of the ACSM regarding type and intensity
of the intervention (e.g., moderate aerobic exercise training
for ≥30min per day on ≥5 days per week or vigorous
aerobic exercise training for ≥20min per day on ≥3 days
per week; on another 2–3 days, resistance exercises for each
of the major muscle groups and flexibility exercises for each
major muscle-tendon groups on ≥2 days per week) (56). For
aerobic training, bicycle ergometers are a widely-used and
practical possibility (also for e.g., patients with arthrosis). The
duration of the intervention should last at least 12 weeks.
Attendance rates, setting (e.g., group activity, with/without
supervision) and training intensity should be monitored,
preferably with spiroergometric examinations at the start and
the end of the study. Follow-up examinations of 3 and 6
months should be performed, and also in this period, information
about antidepressant medication should be provided. On these
occasions, information about the overall fitness level (e.g., via
pedometer/accelerometer measurements over at least 3 days or
via activity questionnaires like IPAQ) should be documented.
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